新基因组学公司
| Security | NEO / NeoGenomics, Inc. |
| Insider | Zook Anthony P. |
This page shows the track record and history of Zook Anthony P.
insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Zook Anthony P. in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Zook Anthony P. in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-06 | 2025-08-06 | 4 | Zook Anthony P. | NEO | Common Stock | D | 5.5840 | 17,900 | 100 | 38,066 | ||||
| 2025-06-03 | 2025-06-01 | 4 | Zook Anthony P. | NEO | Common Stock | D | -3,424 | 20,166 | ||||||
| 2025-06-03 | 2025-06-01 | 4 | Zook Anthony P. | NEO | Common Stock | D | 12,254 | 23,590 | ||||||
| 2025-05-08 | 2025-05-06 | 4 | Zook Anthony P. Amended and Restated Anthony P. Zook Living Trust | NEO | Common Stock | I | 7.8793 | 18,900 | 149 | 18,900 | ||||
| 2024-08-13 | 2024-08-10 | 4 | Zook Anthony P. | NEO | Common Stock | D | 11,336 | 11,336 |
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）
